Temasek and GIC acquire stake in Singapore-headquartered biotech...

adicionou um novo artigo Health

2025-04-01 06:28:12 -

Temasek and GIC acquire stake in Singapore-headquartered biotech specialist CRO Novotech

Novotech, Singapore-headquartered full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund, Novotech said in a statement...

0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior